BioPharma-Reporter.com | By Ben Hargreaves | March 12, 2020 |

The three organizations set up the COVID-19 Therapeutics Accelertor, Back the initiative with $125m.

With the WHO officially announcing the COVID-19 is to be considered a pandemic, three organizations come together to fund the rapid development of potentional antivirals or immunotherpaies agains the coronavirus. Read full article.